No image

THERAPEUTIC DRUG MARKERS LINEARITY VERIFIERS (For Roche Systems)

Therapeutic Drug Markers (TDM) Linearity Verifiers are an in vitro diagnostic product used to assess the linearity of the Roche Systems for Acetaminophen, Amikacin, Carbamazepine, Digoxin, Gentamicin, Lithium, N-Acetylprocainamide, Phenobarbital, Phenytoin, Procainamide, Quinidine, Salicylate, Theophylline, Tobramycin, Valproic Acid and Vancomycin assays.

Details

Device typeMultiple therapeutic drugs/drugs of abuse IVD, control: A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of multiple therapeutic drugs and drugs of abuse in a clinical specimen.

FDA categoryDrug Mixture Control Materials

Device ID05055273216264

Catalog numberLV10355

AvailabilityPrescription

Single useYes

MRI safetyLabeling does not contain MRI Safety Information

Contact

Phone+442894451070

Emailtechnical.services@randox.com

Related products

Product	Model	Company	Device type
MAS PAR TDM Liquid Assayed Therapeutic Drug ControlMicrogenics CorporationMultiple-therapy therapeutic drug monitoring IVD, control	PTD3-3003	Microgenics Corporation	Multiple-therapy therapeutic drug monitoring IVD, control
VigilBeckman Coulter, Inc.Multiple therapeutic drugs/drugs of abuse IVD, control	472461	Beckman Coulter, Inc.	Multiple therapeutic drugs/drugs of abuse IVD, control
TDM/B-Hydroxybutyrate Bi-Level ControlsStanbio Laboratory, L.p.Beta-hydroxybutyrate IVD, control	2465-605	Stanbio Laboratory, L.p.	Beta-hydroxybutyrate IVD, control
Free Phenytoin ControlsRoche Diagnostics GmbHMultiple therapeutic drugs/drugs of abuse IVD, control	20759023322	Roche Diagnostics GmbH	Multiple therapeutic drugs/drugs of abuse IVD, control